Fangfang Zhou (Long Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 57

Top Venues

Signal transduction and targeted therapy

Nature communications

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cellular & molecular immunology

Soochow University

Tsinghua University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Soochow University

China

Professor, Investigator :: Institutes of Biology and Medical Sciences

Leiden University Medical Center

Netherlands

Postdoc :: Department of Molecular Biology

Education History

Tsinghua University

China

PHD :: Department of life science

Publications

Zehua Shang, Sitao Zhang, Jinrui Wang, Lili Zhou, Xinyue Zhang, Daniel D Billadeau, Peiguo Yang, Lingqiang Zhang, Fangfang Zhou, Peng Bai, Da Jia
TRIM25 predominately associates with anti-viral stress granules. Nature communications 15 (1) (2024)
Jiang Ren, Shuai Wang, Zhi Zong, Ting Pan, Sijia Liu, Wei Mao, Huizhe Huang, Xiaohua Yan, Bing Yang, Xin He, Fangfang Zhou, Jisheng Liu
TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. Nature communications 15 (1) (2024)
Zehua Shang, Sitao Zhang, Jinrui Wang, Lili Zhou, Xinyue Zhang, Daniel D Billadeau, Peiguo Yang, Lingqiang Zhang, Fangfang Zhou, Peng Bai, Da Jia
TRIM25 predominately associates with anti-viral stress granules. Nature communications 15 (1) (2024)
Zehua Shang, Sitao Zhang, Jinrui Wang, Lili Zhou, Xinyue Zhang, Daniel D Billadeau, Peiguo Yang, Lingqiang Zhang, Fangfang Zhou, Peng Bai, Da Jia
TRIM25 predominately associates with anti-viral stress granules. Nature communications 15 (1) (2024)
Xiang Wei, Fangfang Zhou, Jisheng Liu
PARP1-DNA co-condensation: the driver of broken DNA repair. Signal transduction and targeted therapy 9 (1) (2024)
Jiang Ren, Shuai Wang, Zhi Zong, Ting Pan, Sijia Liu, Wei Mao, Huizhe Huang, Xiaohua Yan, Bing Yang, Xin He, Fangfang Zhou, Jisheng Liu
TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. Nature communications 15 (1) (2024)
Jiang Ren, Shuai Wang, Zhi Zong, Ting Pan, Sijia Liu, Wei Mao, Huizhe Huang, Xiaohua Yan, Bing Yang, Xin He, Fangfang Zhou, Jisheng Liu
TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. Nature communications 15 (1) (2024)
Jiang Ren, Shuai Wang, Zhi Zong, Ting Pan, Sijia Liu, Wei Mao, Huizhe Huang, Xiaohua Yan, Bing Yang, Xin He, Fangfang Zhou, Jisheng Liu
TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. Nature communications 15 (1) (2024)
Xiang Wei, Fangfang Zhou, Jisheng Liu
PARP1-DNA co-condensation: the driver of broken DNA repair. Signal transduction and targeted therapy 9 (1) (2024)
Zehua Shang, Sitao Zhang, Jinrui Wang, Lili Zhou, Xinyue Zhang, Daniel D Billadeau, Peiguo Yang, Lingqiang Zhang, Fangfang Zhou, Peng Bai, Da Jia
TRIM25 predominately associates with anti-viral stress granules. Nature communications 15 (1) (2024)
Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Peng Su, Yuchen Wu, Feng Xie, Qinghui Zheng, Long Chen, Zhuang Liu, Xuli Meng, Fangfang Zhou, Long Zhang
A Review of Extracellular Vesicles in COVID-19 Diagnosis, Treatment, and Prevention. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Chen Pan, Fangfang Zhou, Jisheng Liu
The loss of epigenetic information: not only consequences but a cause of mammalian aging. Signal transduction and targeted therapy 8 (1) (2023)
Peng Su, Fangfang Zhou, Jisheng Liu
Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium. Signal transduction and targeted therapy 8 (1) (2023)
Chen Pan, Fangfang Zhou, Jisheng Liu
The loss of epigenetic information: not only consequences but a cause of mammalian aging. Signal transduction and targeted therapy 8 (1) (2023)
Qing-Qing Liao, Xin Shu, Wei Sun, Hyma Mandapaka, Feng Xie, Zhengkui Zhang, Tong Dai, Shuai Wang, Jinghua Zhao, Hong Jiang, Long Zhang, Jinzhong Lin, Shu-Wei Li, Irene Coin, Fan Yang, Jinrong Peng, Kui Li, Haifan Wu, Fangfang Zhou, Bing Yang
Capturing Protein-Protein Interactions with Acidic Amino Acids Reactive Cross-Linkers. Small (Weinheim an der Bergstrasse, Germany) (2023)
Ran Li, Jing Zou, Dongling Pei, Ting Pan, Bing Yang, Xianzhi Liu, Yan Chen, Fangfang Zhou, Jisheng Liu
Deciphering dynamic changes of the aging transcriptome with COVID-19 progression and convalescence in the human blood. Signal transduction and targeted therapy 8 (1) (2023)
Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Tong Dai, Lei Zhang, Yu Ran, Meirong Zhang, Bing Yang, Huasong Lu, Shixian Lin, Jisheng Liu, Fangfang Zhou
MAVS deSUMOylation by SENP1 inhibits its aggregation and antagonizes IRF3 activation. Nature structural & molecular biology (2023)
Jizhong Guan, Yao Fan, Shuai Wang, Fangfang Zhou
Functions of MAP3Ks in antiviral immunity. Immunologic research (2023)
Chen Pan, Fangfang Zhou, Jisheng Liu
The loss of epigenetic information: not only consequences but a cause of mammalian aging. Signal transduction and targeted therapy 8 (1) (2023)
Xin Niu, Lei Zhang, Yuchen Wu, Zhi Zong, Bin Wang, Jisheng Liu, Jisheng Liu, Fangfang Zhou
Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. MedComm 4 (2) (2023)
Zhe Li, Shuai Wang, Fangfang Zhou
FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection. Signal transduction and targeted therapy 8 (1) (2023)
Zhe Li, Shuai Wang, Fangfang Zhou
FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection. Signal transduction and targeted therapy 8 (1) (2023)
Yongqiang Wang, Jisheng Liu, Fangfang Zhou
The role of TIA1 and TIAL1 in germinal center B cell function and survival. Cellular & molecular immunology (2023)
Xin Niu, Lei Zhang, Yuchen Wu, Zhi Zong, Bin Wang, Jisheng Liu, Jisheng Liu, Fangfang Zhou
Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. MedComm 4 (2) (2023)
Zhe Li, Shuai Wang, Fangfang Zhou
FXR inhibition: an innovative prophylactic strategy against SARS-CoV-2 infection. Signal transduction and targeted therapy 8 (1) (2023)
Peng Su, Fangfang Zhou, Jisheng Liu
Motile cilia and microvillar: accomplices of SARS-CoV-2 in penetrating mucus barrier and infecting airway epithelium. Signal transduction and targeted therapy 8 (1) (2023)
Zhi Zong, Fangfang Zhou, Jisheng Liu
The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses. Signal transduction and targeted therapy 8 (1) (2023)
Ran Li, Jing Zou, Dongling Pei, Ting Pan, Bing Yang, Xianzhi Liu, Yan Chen, Fangfang Zhou, Jisheng Liu
Deciphering dynamic changes of the aging transcriptome with COVID-19 progression and convalescence in the human blood. Signal transduction and targeted therapy 8 (1) (2023)
Yao Fan, Xiang Li, Lei Zhang, Zhi Zong, Fangwei Wang, Jun Huang, Linghui Zeng, Chong Zhang, Haiyan Yan, Long Zhang, Fangfang Zhou
SUMOylation in Viral Replication and Antiviral Defense. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (7) (2022)
Feng Xie, Xiaoxue Zhou, Heyu Li, Peng Su, Sijia Liu, Ran Li, Jing Zou, Xiang Wei, Chen Pan, Zhengkui Zhang, Min Zheng, Zhuang Liu, Xuli Meng, Huib Ovaa, Peter Ten Dijke, Fangfang Zhou, Jisheng Liu
USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII. The EMBO journal 41 (16) (2022)
Heyu Li, Fangfang Zhou, Long Zhang
STING, a critical contributor to SARS-CoV-2 immunopathology. Signal transduction and targeted therapy 7 (1) (2022)
Bin Wang, Lei Zhang, Yongqiang Wang, Tong Dai, Ziran Qin, Fangfang Zhou, Jisheng Liu
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal transduction and targeted therapy 7 (1) (2022)
Xiang Wei, Feng Xie, Xiaoxue Zhou, Yuchen Wu, Haiyan Yan, Ting Liu, Jun Huang, Fangwei Wang, Fangfang Zhou, Jisheng Liu
Role of pyroptosis in inflammation and cancer. Cellular & molecular immunology 19 (9) (2022)
Yifan Xie, Feng Xie, Xiaoxue Zhou, Lei Zhang, Bing Yang, Jun Huang, Fangwei Wang, Haiyan Yan, Linghui Zeng, Jisheng Liu, Fangfang Zhou
Microbiota in Tumors: From Understanding to Application. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (21) (2022)
Yao Fan, Xiang Li, Lei Zhang, Shu Wan, Long Zhang, Fangfang Zhou
SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal transduction and targeted therapy 7 (1) (2022)
Feng Xie, Xiaoxue Zhou, Peng Su, Heyu Li, Yifei Tu, Jinjin Du, Chen Pan, Xiang Wei, Min Zheng, Ke Jin, Liyan Miao, Chao Wang, Xuli Meng, Hans van Dam, Peter Ten Dijke, Jisheng Liu, Fangfang Zhou
Breast cancer cell-derived extracellular vesicles promote CD8 + T cell exhaustion via TGF-β type II receptor signaling. Nature communications 13 (1) (2022)
Jiang Ren, Zhenyu Zhang, Zhi Zong, Long Zhang, Fangfang Zhou
Emerging Implications of Phase Separation in Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9 (31) (2022)
Yongqiang Wang, Fangfang Zhou, Fangfang Zhou
Cuproptosis: a new form of programmed cell death. Cellular & molecular immunology 19 (8) (2022)
Ziran Qin, Xiuwu Fang, Wenhuan Sun, Zhenyu Ma, Tong Dai, Shuai Wang, Zhi Zong, Huizhe Huang, Heng Ru, Huasong Lu, Bing Yang, Shixian Lin, Fangfang Zhou, Jisheng Liu
Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity. Nature immunology 23 (8) (2022)
Feng Xie, Peng Su, Ting Pan, Xiaoxue Zhou, Heyu Li, Huizhe Huang, Aijun Wang, Fangwei Wang, Jun Huang, Haiyan Yan, Linghui Zeng, Jisheng Liu, Fangfang Zhou
Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID-19 Therapy. Advanced materials (Deerfield Beach, Fla.) (2021)
Bin Wang, Tong Dai, Wenhuan Sun, Yujun Wei, Jiang Ren, Long Zhang, Mengdi Zhang, Fangfang Zhou
Protein N-myristoylation: functions and mechanisms in control of innate immunity. Cellular & molecular immunology 18 (4) (2021)
Shuai Wang, Tong Dai, Ziran Qin, Ting Pan, Feng Chu, Lingfeng Lou, Jisheng Liu, Bing Yang, Huizhe Huang, Huasong Lu, Fangfang Zhou
Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity. Nature cell biology 23 (7) (2021)
Yifan Xie, Feng Xie, Lei Zhang, Xiaoxue Zhou, Jun Huang, Fangwei Wang, Jin Jin, Long Zhang, Linghui Zeng, Fangfang Zhou
Targeted Anti-Tumor Immunotherapy Using Tumor Infiltrating Cells. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (22) (2021)
Ke Jin, Fangfang Zhou, Jisheng Liu
Cancer Environment Immunotherapy: targeting TGF-β finds its way towards tissue healing and vasculature remodeling. Signal transduction and targeted therapy 6 (1) (2021)
Bin Wang, Lei Zhang, Tong Dai, Ziran Qin, Huasong Lu, Jisheng Liu, Fangfang Zhou
Liquid-liquid phase separation in human health and diseases. Signal transduction and targeted therapy 6 (1) (2021)
Yetian Dong, Tong Dai, Bin Wang, Lei Zhang, Ling-Hui Zeng, Jun Huang, Haiyan Yan, Jisheng Liu, Fangfang Zhou
The way of SARS-CoV-2 vaccine development: success and challenges. Signal transduction and targeted therapy 6 (1) (2021)
Haodong Guo, Lili Zhou, Zhenyu Ma, Zhixin Tian, Fangfang Zhou
Promising Immunotherapies against COVID-19. Advanced therapeutics (2021)
Zhi Zong, Yujun Wei, Jiang Ren, Long Zhang, Fangfang Zhou
The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Molecular cancer 20 (1) (2021)
Yao Fan, Jisheng Liu, Fangfang Zhou
cGAS-like receptors: new RNA sensors in Drosophila. Signal transduction and targeted therapy 6 (1) (2021)
Lili Zhou, Yuqi Zhang, Yongqiang Wang, Meirong Zhang, Wenhuan Sun, Tong Dai, Aijun Wang, Xiaojin Wu, Suping Zhang, Shuai Wang, Fangfang Zhou
A Dual Role of Type I Interferons in Antitumor Immunity. Advanced biosystems 4 (11) (2020)
Zhi Zong, Zhengkui Zhang, Liming Wu, Long Zhang, Fangfang Zhou
The Functional Deubiquitinating Enzymes in Control of Innate Antiviral Immunity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (2) (2020)
Xiaoxue Zhou, Feng Xie, Lin Wang, Long Zhang, Suping Zhang, Meiyu Fang, Fangfang Zhou
The function and clinical application of extracellular vesicles in innate immune regulation. Cellular & molecular immunology 17 (4) (2020)
Liang Gao, Lin Wang, Tong Dai, Ke Jin, Zhengkui Zhang, Shuai Wang, Feng Xie, Pengfei Fang, Bing Yang, Huizhe Huang, Hans van Dam, Fangfang Zhou, Jisheng Liu
Tumor-derived exosomes antagonize innate antiviral immunity. Nature immunology 19 (3) (2018)
Zhengkui Zhang, Yao Fan, Feng Xie, Hang Zhou, Ke Jin, Li Shao, Wenhao Shi, Pengfei Fang, Bing Yang, Hans van Dam, Peter Ten Dijke, Xiaofeng Zheng, Xiaohua Yan, Junling Jia, Min Zheng, Jin Jin, Chen Ding, Sheng Ye, Fangfang Zhou, Jisheng Liu
Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7. Nature communications 8 (1) (2017)

Fangfang Zhou.css-eqlu8i{font-size:small;padding-left:4px;} (Long Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Fangfang Zhou (Long Zhang)